Democratic presidential candidate Barack Obama’s health plan continues to hold a lead over the plan put forth by Republican John McCain in a survey being conducted at DiagnosticImaging.com.
Democratic presidential candidate Barack Obama's health plan continues to hold a lead over the plan put forth by Republican John McCain in a survey being conducted at DiagnosticImaging.com. As of Oct. 20, the survey had received 231 votes. Obama's plan was favored by 45% and McCain's by 40%. Another 6% favored a different plan, 6% favored no plan, and 3% were undecided. The survey was posted on Oct. 7 and is scheduled to run until the Nov. 4 election. The poll is an unscientific snapshot of site visitor opinion. Though prone to sampling bias, it is structured to prevent multiple votes from individual sources. Final results will be reported at DiagnosticImaging.com. A similar survey is appearing at CancerNetwork.com, a site run by two oncology publications under the same corporate banner as Diagnostic Imaging. A separate web poll being run by Epocrates found slightly higher support for the Obama plan, 47% to McCain's 30%, with 23% of respondents answering neither. As of Oct. 20, 1179 respondents had voted. That poll started Oct. 3.
Among the highlights of the Epocrates poll are the following findings:
For more information from the Diagnostic Imaging archives:
Four Strategies to Address the Tipping Point in Radiology
January 17th 2025In order to flip the script on the impact of the radiology workforce shortage, radiology groups and practices need to make sound investments in technologies and leverage partnerships to mitigate gaps in coverage and maximize workflow efficiencies.
Can Generative AI Facilitate Simulated Contrast Enhancement for Prostate MRI?
January 14th 2025Deep learning synthesis of contrast-enhanced MRI from non-contrast prostate MRI sequences provided an average multiscale structural similarity index of 70 percent with actual contrast-enhanced prostate MRI in external validation testing from newly published research.
Can MRI-Based AI Enhance Risk Stratification in Prostate Cancer?
January 13th 2025Employing baseline MRI and clinical data, an emerging deep learning model was 32 percent more likely to predict the progression of low-risk prostate cancer (PCa) to clinically significant prostate cancer (csPCa), according to new research.